Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
- 17 April 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (10), 5815-5820
- https://doi.org/10.1073/pnas.081612998
Abstract
Biochemical, epidemiological, and genetic findings demonstrate a link between cholesterol levels, processing of the amyloid precursor protein (APP), and Alzheimer's disease. In the present report, we identify the alpha-secretase ADAM 10 (a disintegrin and metalloprotease) as a major target of the cholesterol effects on APP metabolism. Treatment of various peripheral and neural cell lines with either the cholesterol-extracting agent methyl-beta-cyclodextrin or the hydroxymethyl glutaryl-CoA reductase inhibitor lovastatin resulted in a drastic increase of secreted alpha-secretase cleaved soluble APP. This strong stimulatory effect was in the range obtained with phorbol esters and was further increased in cells overexpressing ADAM 10. In cells overexpressing APP, the increase of alpha-secretase activity resulted in a decreased secretion of Abeta peptides. Several mechanisms were elucidated as being the basis of enhanced alpha-secretase activity: increased membrane fluidity and impaired internalization of APP were responsible for the effect observed with methyl-beta-cyclodextrin; treatment with lovastatin resulted in higher expression of the alpha-secretase ADAM 10. Our results demonstrate that cholesterol reduction promotes the nonamyloidogenic alpha-secretase pathway and the formation of neuroprotective alpha-secretase cleaved soluble APP by several mechanisms and suggest approaches to prevention of or therapy for Alzheimer's disease.Keywords
This publication has 55 references indexed in Scilit:
- Coordinated Expression of β‐Amyloid Precursor Protein and the Putative β‐Secretase BACE and α‐Secretase ADAM10 in Mouse and Human BrainJournal of Neurochemistry, 2000
- Cleavage of Alzheimer's Amyloid Precursor Protein by α-Secretase Occurs at the Surface of Neuronal CellsBiochemistry, 1999
- Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium HomeostasisJournal of Biological Chemistry, 1998
- Caveolae, Plasma Membrane Microdomains for α-Secretase-mediated Processing of the Amyloid Precursor ProteinJournal of Biological Chemistry, 1998
- Cholesterol as Modulator of Receptor FunctionBiochemistry, 1997
- Caveolin, a protein component of caveolae membrane coatsCell, 1992
- Trophic effect of β-amyloid precursor protein on cerebral cortical neurons in cultureBiochemical and Biophysical Research Communications, 1991
- Defective utilization of cholesterol esters from low-density lipoprotein in a human acute lymphoblastic leukemia T cell lineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959